Study of worsening community pneumonia in people with weaker immunity
Part of Infections, Lungs & breathing clinical trials.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized with community-acquired pneumonia (CAP) confirmed on a chest X-ray or CT scan
- A doctor believes the main reason for admission is pneumonia, and you can provide consent
- You have not been hospitalized in the past 28 days for any reason
- You have at least 2 pneumonia symptoms such as fever, cough, thick/yellow mucus, trouble breathing, or abnormal lung exam findings
- You have at least one major risk factor such as HIV/AIDS, recent cancer treatment, long-term steroids, or other serious conditions (like dialysis-dependent kidney disease or advanced heart or liver disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at adults with pneumonia to better understand how severe the infection is and how it may affect recovery. By joining, you will help doctors learn more about predicting outcomes for people with similar conditions.
This study looks at medical records from adults who have pneumonia with a confirmed germ, to better understand how the disease develops and how people recover. It may help guide future care decisions.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
This registry study collects information from patients hospitalized with pneumonia who also have a weakened immune system. The goal is to better understand how to treat and manage pneumonia in people like you.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.